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Introduction
Lipids are essential for life, and the existence of cells special-
ized in fat storage has been conserved from flies and worms to 
humans. However, almost all cells maintain the capability to re-
tain and accumulate lipids. Cellular mechanisms of lipid stor-
age are relatively conserved from unicellular organisms, such 
as yeast, to complex organisms such as plants and mammals 
(Chapman et al., 2012; Kühnlein, 2012; Mak, 2012; Walther 
and Farese, 2012). Indeed, in all eukaryotic and some prokary-
otic cells, lipid droplets (LDs; Fig. 1, A and C) are the intra-
cellular organelle specialized in assembling, storing, and then 
supplying lipids. For decades considered passive cytosolic in-
clusions, LDs are now understood as being complex and dy-
namic organelles, with a central role in the regulation of lipid 
homeostasis. LDs provide substrates for energy metabolism, 
membrane synthesis, and production of essential lipid-derived 
molecules such as lipoproteins, bile salts, or hormones.
Cellular lipid storage varies, and reflects a balance be-
tween lipid arrival and lipid consumption; excessive accumula-
tion of LDs occurs in fat-related diseases, such as obesity and 
arteriosclerosis (Krahmer et al., 2013). However, although the 
balance between supply and consumption determines LD lev-
els, LD accumulation is remarkably heterogeneous even be-
tween otherwise identical cells (Herms et al., 2013). Interestingly, 
factors such as intracellular and extracellular stresses trigger 
LD formation (Hapala et al., 2011), reflecting a role for LDs in 
processes not directly related to lipid metabolism, such as pro-
tein degradation or immunity. Indeed, accumulation of LDs also 
occurs during progression of pathologies not obviously related 
to lipids, such as cardiomyopathies, neuropathies, or during viral 
hepatitis caused by, among others, the human immunodeficiency 
virus (Vallet-Pichard et al., 2012).
In eukaryotes, LDs likely form de novo by progressive ac-
cumulation of neutral lipids in the ER (Fig. 1, B and D–F), al-
though fission of preexisting LDs has been also suggested as 
a mechanism to generate new LDs in yeast (Long et al., 2012). 
Multiple enzymatic reactions contribute to LD assembly and nu-
merous bioactive lipid intermediates are synthesized and trans-
formed (Fig. 2). LD formation is regulated by complex and robust 
mechanisms, often conducted by apparently redundant activi-
ties of enzymes and structural proteins. For example, at least 
eleven mammalian acyl-CoA synthetases (ACSs) can activate 
major long-chain fatty acids, and thus potentially initiate the 
synthesis of neutral lipids (Watkins et al., 2007). At the other 
end of the pathway, in humans, at least twelve genes of three 
different acyltransferase families produce enzymes capable of 
catalyzing the last step of neutral lipid synthesis (Sturley and 
Hussain, 2012). Such complexity and functional compensation 
likely reflects the physiological significance of the LD, and 
enormously complicates determining how particular proteins 
and lipids contribute to LD assembly and metabolism. This re-
view will summarize our current understanding of where and 
how LDs are formed, and in what way LD formation requires 
coordination of: (1) fatty acid activation, (2) synthesis of neutral 
Lipid droplets (LDs) are ubiquitous dynamic organelles 
that store and supply lipids in all eukaryotic and some 
prokaryotic cells for energy metabolism, membrane syn-
thesis, and production of essential lipid-derived molecules. 
Interest in the organelle’s cell biology has exponentially 
increased over the last decade due to the link between 
LDs and prevalent human diseases and the discovery of 
new and unexpected functions of LDs. As a result, there 
has been significant recent progress toward understand-
ing where and how LDs are formed, and the specific lipid 
pathways that coordinate LD biogenesis.
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Figure 1. Morphology of LDs. (A) AML-12 cells were treated for 16 h with BSA-bound oleic acid. Cells were fixed and neutral lipids stained with Nile red. 
The image combines images of confocal microscopy (red) and differential interference contrast images (DIC, black and white). Gray lines indicate the con-
tour of the cells. Image courtesy of Albert Herms. (B) COS-1 cells were cotransfected with OFP-HPos (an LD marker, red) and GFP-HNeu (ER marker, green) 
and cells were lipid starved during 24 h to reduce the presence of LDs. Then cells were loaded with BSA-bound oleic acid for 7.5 min and the segregation 
of the markers analyzed by confocal microscopy. The red globular structures correspond to the fatty acid–induced LDs and the inset shows a high magni-
fication image of one of these LDs. The images are from Kassan et al. (2013). (C) Cells treated as in B, but for 24 h, were fixed and neutral lipids stained 
with Nile red and the nuclei with DAPI (blue). Lipid droplets are visible both by confocal microscopy (left) and DIC (right). White dotted lines indicate the 
contour of the cell. Image courtesy of Albert Herms. (D and E) LDs induced to form in COS-1 cells were analyzed by electron tomography. The images shows 
selected low magnification (D) and high magnification (E) sections in which the LD monolayer (green arrow) contacts (white arrow) with the other LDs or the 
ER bilayer (red arrow), which is recognized by the presence of electron-dense ribosomes (blue arrow). These LDs have an average diameter of 250 nm and 
thus are nascent or very early LDs. Image from Kassan et al. (2013). (F) Schematic representation of a model of LD biogenesis. Lipid globules produced 
during triacylglycerol synthesis and deposited between the two ER leaflets of the bilayer that laterally move unless they are nucleated. This nucleation marks 
the onset of LD biogenesis. From here, LD expansion (sizes are indicated) can be accomplished by recruitment of additional proteins, accumulation of new 
lipids locally and distally produced, and the synthesis of new phospholipids and lysophospholipids. Finally, the concave nascent LD will be converted into 
the globular early LD, move into central regions of the cell, and form a mature LD that shows a relatively constant size (Kassan et al., 2013).
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Neutral lipid synthesis “within” and 
“outside” LDs
Although their relative amount varies between cell types, the 
most abundant neutral lipids in LDs are triacylglycerol and cho-
lesterol esters (sterol esters in yeast and Drosophila). While in 
adipocytes, caveolae may contribute to triacylglycerol synthesis 
(Ost et al., 2005); in most cells neutral lipid synthesis is con-
ducted by enzymes permanently or transiently located in the 
ER. De novo triacylglycerol synthesis occurs in four reactions, 
catalyzed by members of the glycerol-3-phosphate O-acyltrans-
ferase (GPAT), 1-acylglycerol-3-phosphate O-acyltransferase 
(AGPAT), phosphatidic acid phosphatase (PAP)/lipin, and DGAT 
enzyme families (Fig. 2, orange box). The final step in this path-
way is esterification of diacylglycerol into triacylglycerol con-
ducted by DGAT1 and DGAT2 (Dga1p in yeast; Sturley and 
Hussain, 2012), which accounts for nearly all triacylglycerol 
synthesis in mouse cells (Harris et al., 2011). Nevertheless, al-
ternative mechanisms have been proposed (Harris et al., 2011; 
Sturley and Hussain, 2012), and in plants and yeast, phospho-
lipid:diacylglycerol O-acyltransferase (PDTA) and Lro1p can 
also produce triacylglycerol through trans-esterification of a 
fatty acid from phospholipids (Chapman et al., 2012; Czabany 
et al., 2008). In addition, LDs accumulate free cholesterol in 
adipocytes (Krause and Hartman, 1984) and cholesterol esters 
in most cells, especially in macrophages and steroidogenic cells. 
The synthesis of cholesterol esters is mediated by acyl-CoA:
cholesterol O-acyltransferase (ACAT1 and ACAT2, Are1p and 
Are2p in yeast). Yeast strains with deletions of all four acyl-
transferases (ARE1, ARE2, DGA1, and LRO1) completely 
lack LDs and although viable, have a marked sensitivity to the 
lipotoxicity caused by fatty acids (Garbarino et al., 2009).
In cells lacking LDs, these enzymes are distributed ho-
mogenously along the ER, with the exception of PAP (Pah1p in 
yeast), which is largely cytosolic and in animal cells localizes to 
the nucleus. When LD formation is promoted with fatty acids, 
enzyme segregation occurs, with some remaining in the ER and 
others dynamically accumulating on the LDs. Specifically, a 
permanent ER location has been shown for AGPAT1, AGPAT2, 
AGPAT4, and DGAT1 in Drosophila cells (Wilfling et al., 2013); 
for Lro1p, Are1p, and Are2p in yeast (Zweytick et al., 2000; 
Jacquier et al., 2011); and for DGAT1, ACAT1, and ACAT2 in 
mammalian cells (Khelef et al., 1998; Stone et al., 2009). How-
ever, these LD-excluded enzymes efficiently promote LD for-
mation (Harris et al., 2011; Jacquier et al., 2011), suggesting that 
neutral lipids can be synthesized along the ER tubules, diffuse 
laterally, and somehow nucleate to assemble LDs.
Interestingly, triacylglycerol synthesis can also occur lo-
cally on LDs and at least one member of each family required 
for de novo synthesis is present on LDs. The accumulation on 
LDs has been described for GPAT4, AGPAT3, PAP, and DGAT2 
in flies or mammals (Fig. 3, orange box; Kuerschner et al., 2008; 
Stone et al., 2009; Wang et al., 2011; Wilfling et al., 2013) and 
for Gat1p, Gat2p, Pah1p, and Dga1p in yeast (Athenstaedt and 
Daum, 1997; Adeyo et al., 2011; Jacquier et al., 2011). Thus, 
such accumulation reflects enzymes that laterally segregate 
from the ER into LDs. For Dga1p in yeast, such LD accumula-
tion is independent of temperature and energy, and thus does 
lipids, (3) remodeling of phospholipids, (4) synthesis of new 
phospholipids, and (5) function of accessory proteins. Finally, 
these biochemical reactions will be integrated in a single model 
to describe mechanisms and sites of LD biogenesis.
Fatty acid activation and multi-enzymatic 
complexes on LDs
Many reactions occurring during LD biogenesis require an acyl-
CoA. Fatty acids are chemically inert, and thus must be acti-
vated by esterification with coenzyme A (CoA). This occurs in 
an ATP-dependent two-step reaction, catalyzed by ACS (Fig. 2, 
green box; Ellis et al., 2010). The proposed LD-bound ACS 
members are ACSL1, ACSL3, and ACSL4. Inhibition of these 
ACSLs with Triacsin C (Tomoda et al., 1987) highly reduces 
triacylglycerol synthesis (Igal and Coleman, 1996), and thus com-
pletely inhibits the formation of LDs promoted by fatty acids 
(Kassan et al., 2013).
Interestingly, the ACSL family members are differentially 
regulated during 3T3-L1 adipocyte differentiation: ACSL1 is 
up-regulated, but ACSL3 is down-regulated (Sandoval et al., 
2008), suggesting that each could be involved in different as-
pects of LD metabolism. Some studies differ regarding LD as-
sociation of ACSL1 and ACSL4 (Brasaemle et al., 2004; Liu 
et al., 2004; Poppelreuther et al., 2012; Wilfling et al., 2013), 
but ACSL3 is definitely a bona fide LD protein (Brasaemle 
et al., 2004; Fujimoto et al., 2004, 2007). ACSL3 was linked to 
cellular lipid uptake, and a peptide comprising the N-terminal 
domain of ACSL3 was shown in early LDs (Poppelreuther et al., 
2012). Indeed, in COS-1–cultured cells, endogenous ACSL3 is 
recruited early to LD assembly sites, and is required for efficient 
LD nucleation (Kassan et al., 2013). The absence of ACSL3 sig-
nificantly reduces fatty acid–induced formation of LDs and the 
short- and long-term accumulation of neutral lipids. However, 
because ACSL3 is highly down-regulated in mature 3T3 adipo-
cytes, it is likely that factors other than ACSL3 assist LD nucle-
ation and expansion in specialized cells.
The roles of ACS proteins during LD biogenesis might go 
beyond their enzymatic activity (Kassan et al., 2013). Some ACS 
proteins are fatty acid transporters (FATPs; Doege and Stahl, 2006), 
some regulate fatty acid uptake (Füllekrug et al., 2012), and be-
cause ACS activity modifies the cellular AMP/ATP ratio, they are 
also likely involved in metabolic signaling via AMP kinases (Ellis 
et al., 2010). Further, ACS proteins form complexes with other pro-
teins, and thus potentially organize specific microdomains in the 
ER. Complexes of neutral lipid synthesis enzymes and synthetase 
activities were demonstrated in early studies (Rao and Johnston, 
1966); such complexes likely increase efficiency of neutral lipid 
production by rapidly transferring substrates from one enzyme to 
the next (Wilfling et al., 2013). For example, in Caenorhabditis 
elegans, a fatty acid transport protein 1 (FATP1)/diacylglycerol 
acyltransferase 2 (DGAT2) complex was located at the ER–LD 
interface, and proposed to couple neutral lipid synthesis and de-
position (Xu et al., 2012). Finally, ACSL3 physically interacts with 
other LD proteins such as Spartin/SPG20 and the ancient ubiqui-
tous protein 1 (AUP1), which are in turn crucial adaptor proteins 
that determine LD size and numbers (Eastman et al., 2009; 
Milewska et al., 2009; Klemm et al., 2011; Spandl et al., 2011).
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Figure 2. Lipid metabolism and LD formation. LD biogenesis requires coordination of fatty acid activation by acyl-CoA synthetases (green box), de novo 
synthesis of neutral lipids (orange box), the Lands cycle of phospholipid remodeling (purple box), the Kennedy pathway of phospholipid synthesis (blue 
box), and the function of accessory proteins (gray box). The enzymes involved in these pathways are indicated with red (mammal) and yellow letters (yeast), 
the acyl-CoA with purple letters, the lipid intermediates with black letters, and other required molecules with blue letters. See details of lipolysis mechanisms 
in Zechner et al. (2012).
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recruitment of key proteins involved in LD formation and func-
tion including perilipin 3 (Plin3; Skinner et al., 2009), CTP:phos-
phocholine cytidylyltransferase (CCT; Krahmer et al., 2011), and 
protein kinase C (PKC; Chen et al., 2002; Suzuki et al., 2013).
The Lands cycle and membrane remodeling
The turnover of glycerophospholipid acyl chains in cycles of 
deacylation and reacylation catalyzed by phospholipase A (PLA) 
and lysophospholipid acyltransferase enzymes is known as the 
Lands cycle of phospholipid remodeling (Fig. 2, purple box; 
Lands, 2000). It is both an alternative source of phosphatidyl-
choline (see next section) and triacylglycerol (see previous sec-
tion), and also contributes to dynamic remodeling of membranes. 
That the Lands cycle contributes to LD biogenesis is suggested 
by the fact that PLA2 inhibitors strongly reduce LD formation 
(Gubern et al., 2008; Du et al., 2009). Similar to the genetic de-
letion of yeast PAH1, loss of PLA2 activity inhibits LD assembly 
without impairing triacylglycerol formation. An LD-associated 
PLA2 has been described in hepatoma cell lines (Sato et al., 
2006) and the yeast LD enzyme Tgl4p also exhibit PLA2 activ-
ity (Rajakumari and Daum, 2010b).
For the lysophospholipid acyltransferase portion of the 
Lands cycle, in addition to AGAPT3 (a lysophosphatidic acid 
acyltransferase, LPAAT), mammalian LDs also contain lyso-
phosphatidylcholine acyltransferase (LPCAT) with activity on 
lysophosphatidylcholine (Moessinger et al., 2011). In yeast, 
Loa1p (a LPAAT) is also present on LDs; its overexpression re-
sults in fewer LDs, suggesting a direct role of lysophosphatidic 
acid during LD formation (Ayciriex et al., 2012). Further, likely 
indicating the importance of this cycle, the yeast LD enzymes 
Tgl3p and Tgl5p also catalyze acylation of lysophosphatidyl-
ethanolamine and lysophosphatidic acid (Rajakumari and Daum, 
2010a). Dynamic turnover between lysophospholipids and phos-
pholipids, conically and cylindrically shaped, respectively, could 
be required to curve initially the ER membrane and next to pro-
gressively adapt the membrane curvature in order to shield the 
underlying globule in each step of the biogenesis process.
Membrane remodeling by the Lands cycle is best charac-
terized in the Golgi complex (Ha et al., 2012), where dynamic 
equilibrium between the activities of PLA2 and AGPAT3 deter-
mines the relative abundance of vesicles and tubules (Yang 
et al., 2011). This might be analogous to a role in LDs, promot-
ing LD formation from ER tubules. Consistent with this general 
picture, in the Golgi complex, the final step of COPI vesicle fis-
sion requires activity of phospholipase D (PLD) to hydrolyze 
phosphatidylcholine into phosphatidic acid; for LDs, the phos-
phatidic acid produced by PLD is needed for LD generation in 
a microsome-based cell-free system (Marchesan et al., 2003). 
How mechanisms for shaping phospholipid bilayers also func-
tion on monolayers clearly deserves further investigation.
Phospholipid synthesis for LD expansion 
and to avoid coalescence
When LDs expand, the phospholipid content of the LD must 
also increase. This is likely critical during the initial stages of 
the LD growth process, in which the nascent structures grow 
rapidly. In yeast and mammalian LDs, phosphatidylcholine is 
not require vesicle formation (Jacquier et al., 2011). Although 
not completely understood, it is mediated by a hairpin topology 
of the hydrophobic regions of these proteins, or an equivalent 
favorable folding (Walther and Farese, 2012), in combination 
with additional information, such as sequences of positive 
amino acids (Ingelmo-Torres et al., 2009). In contrast, enzymes 
with membrane-spanning helices (Stevanovic and Thiele, 2013) 
or without positive sequences (Kassan et al., 2013) remain lo-
calized in the ER during LD formation. The length and hydro-
phobicity of the hydrophobic regions, and the proximity of flanking 
positive residues, also determine whether the tail- and signal-
anchored proteins are targeted to peroxisomes, chloroplasts, 
mitochondria, or the ER (Borgese et al., 2007). Interestingly, 
specific deletions within some LD-resident proteins localize 
the mutants to mitochondria (Nakamura and Fujimoto, 2003; 
Suzuki et al., 2005). Intriguingly, DGAT2 simultaneously con-
tains signals to be sorted into the ER–LDs or mitochondria 
(Stone et al., 2009). Whether the positive residues of LD pro-
teins are recognized by specific receptors, chaperones, or lipid 
species (as demonstrated for tail- and signal-anchored proteins) 
remains to be elucidated.
In contrast to these enzymes arriving from the ER, PAP 
associates with LDs from the cytosol, regulated by phosphory-
lation. The yeast homologue, Pah1p, is dephosphorylated by the 
ER-resident phosphatase complex Nem1p–Spo7p, and is phos-
phorylated by Cdc28p kinase. When Pah1p is dephosphorylated 
it binds to the ER membrane through an amphipathic helix 
(Karanasios et al., 2010). Nem1p also localizes next to LDs, and 
it was suggested that it marks the ER sites of LD biogenesis 
(Adeyo et al., 2011). Overexpression of Nem1p–Spo7p recruits 
Pah1p in the vicinity of LDs and induces LD formation 
(Karanasios et al., 2013). Whether Dullard (Nem1p homologue) 
or the cyclin-dependent kinase 1 (CDK1, Cdc28p homologue) 
are involved in mammalian LD nucleation also remains to be 
analyzed. However, this scenario is much more complex in mam-
malian cells: mammals express at least three PAP paralogues 
(lipin 1, 2, and 3), with several isoforms, intracellular distribu-
tions, and expression patterns (Siniossoglou, 2013). Neverthe-
less, it has been shown that lipin 1 has affinity for LDs (Wang 
et al., 2011) and a role of lipins in LD biogenesis has been re-
cently proposed (Sembongi et al., 2013).
In addition to triacylglycerol, diacylglycerol is also pres-
ent in LDs (Kuerschner et al., 2008). In early LD biogenesis, 
diacylglycerol likely generates both membrane curvature and 
provides a platform for protein binding. In yeast, diacylglycerol 
produced by Pah1p is critical for LD formation even when the 
LDs primarily contain sterol esters (Adeyo et al., 2011). In the 
absence of Pah1p, neutral lipids accumulate in the ER in a dis-
organized arrangement; this might also occur in mammalian 
cells (Sembongi et al., 2013). Interestingly, yeast strains with 
deletions in diacylglycerol kinase (DGK1) have more LDs 
even when triacylglycerol synthesis is blocked. Similarly, the 
balance between diacylglycerol and phosphatidic acid regulates 
membrane tubulation and vesicle formation in the Golgi com-
plex, by mechanisms that involve membrane remodeling and 
protein recruitment (Fei et al., 2011a; Malhotra and Campelo, 
2011). On LDs, diacylglycerol could play an important role in 
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seem to be ER derived, activity of mitochondria and peroxi-
somes is also required for LD formation.
Accessory proteins with unclear roles
The number of proteins described on LDs has grown exponen-
tially (Yang et al., 2012). Nevertheless, a protein essential for 
LD formation has not been identified. However, the existence of 
functional compensation between structural proteins (Sztalryd 
et al., 2006) makes identification of a single indispensable scaf-
fold unlikely.
Two ER proteins have been proposed to play structural 
roles during LD formation; seipin (Fld1p in yeast) and the fat 
storage–inducing transmembrane protein (FITM/FIT; Fig. 3, 
gray box). Both have membrane-spanning helices (two for 
seipin and six for FIT) and thus in principle might function from 
outside the emerging LD (Gross et al., 2010; Cartwright and 
Goodman, 2012). Indeed, reduced levels of FIT2 in cultured 
adipocytes or zebrafish decreases triacylglycerol storage in LDs, 
and overexpression of FIT1/FIT2 in cells, liver, and muscle in-
creases accumulation of triacylglycerol in LDs (Kadereit et al., 
2008; Miranda et al., 2011). On the other hand, ablation of 
seipin in yeast and in fibroblasts results in small, irregular 
LDs, but also in supersized LDs (Szymanski et al., 2007; Fei 
et al., 2008). Due to conflicting results from different systems, 
the role of seipin in LD formation is still unclear. For example 
seipin overexpression causes the opposite effect, reducing ac-
cumulation of triacylglycerol in HeLa cells and adipocytes (Fei 
et al., 2011b; Cui et al., 2012). Both of these proteins have been 
hypothesized to contribute to filling LDs with neutral lipids, 
phospholipids, or proteins (Gross et al., 2011; Cartwright and 
Goodman, 2012). Indeed, seipin is located at ER–LD junctions 
in yeast (Szymanski et al., 2007). However, Dga1p moves into 
LDs even in seipin mutant cells (Jacquier et al., 2011), suggest-
ing that protein transfer is not affected, and that triacylglycerol 
can be still produced locally on LDs. In contrast, because the 
last step of the Kennedy pathway mediated by CPT occurs in 
the ER, but not locally on LDs, deficient ER–LD transport could 
modify the incorporation of phospholipids into the LD (Fei 
et al., 2011a). Alternatively, it was also suggested that seipin 
regulates lipolysis (Fei et al., 2011b).
The accumulation of LDs is the result of a dynamic bal-
ance between neutral lipid synthesis and neutral lipid lipolysis 
(Herms et al., 2013). Regulation of lipolysis seems to be the 
primary function of perilipins, a family of five related members 
collectively termed Plin proteins (Kimmel et al., 2010). The 
best-characterized Plin proteins control lipolysis by recruiting 
or preventing access of lipases on LDs (Bickel et al., 2009). In 
adipocytes, emerging LDs are coated first with Plin3 and Plin4, 
next with Plin2, and finally with Plin1 (Wolins et al., 2006). 
This interesting observation demonstrates, as previously with 
ACSL, that LD formation and expansion follows a stepwise and 
synchronized maturation process. However, Plin1, Plin4, and 
Plin5 expression is limited to a few tissues (Brasaemle and Wolins, 
2012). In contrast, Plin2 and Plin3 are ubiquitously expressed 
and coat LDs in the majority of cells. In mammalian cells, Plin3 
is recruited to the ER during LD biogenesis by recognition of 
the initial accumulation of diacylglycerol (Skinner et al., 2009) 
the major phospholipid (50–60%), followed by phosphatidyl-
ethanolamine (20–30%), phosphatidylinositol, and ether-linked 
species with choline and ethanolamine headgroups (Tauchi-Sato 
et al., 2002; Bartz et al., 2007). In contrast, Drosophila LDs 
contain more phosphatidylethanolamine (50–60%) than phos-
phatidylcholine (20–25%; Krahmer et al., 2011). Such an im-
portant difference, in addition to the proposal that expansion of 
mature LDs requires very few phospholipids (Penno et al., 2013), 
suggests that rather than the initial phospholipid composition, a 
dynamic turnover between different species of phospholipids and 
lysophospholipids is important during LD formation.
Two major pathways contribute to phosphatidylcholine 
synthesis: the Kennedy pathway for de novo synthesis of phos-
pholipids (Fig. 2, blue box) and the Lands cycle (Fig. 2, purple 
box). In the Kennedy pathway, the rate-limiting enzyme is CCT. 
Before induction of LD formation, CCT1 localizes to the nu-
cleus. However, after loading cells with fatty acids, CCT1 and 
CCT2 (but not choline kinase or CDP-cholinephosphotransferase 
[CPT]) localize to LDs (Krahmer et al., 2011). CCT binds to 
membranes depleted of phosphatidylcholine (Jamil et al., 1990), 
and in vitro CCT is activated by diacylglycerol and phospha-
tidic acid (Cornell and Northwood, 2000). Thus, as an LD 
grows, a relative depletion of phosphatidylcholine and the en-
richment in diacylglycerol and phosphatidic acid will promote 
CCT binding and activation. In Drosophila cells, CCT1 accu-
mulates on LDs containing complexes of neutral lipid synthesis 
enzymes (Wilfling et al., 2013). However, the final step in the 
pathway—using diacylglycerol as a substrate—is catalyzed by 
CPT, an integral membrane protein of the ER (Krahmer et al., 
2011). Thus, the newly synthesized phosphatidylcholine is ac-
tually produced in the ER and needs to be transferred from the 
ER to the LD.
Like triacylglycerol, phosphatidylcholine can also be pro-
duced locally on LDs, now by the Lands cycle. The Lands cycle 
and the Kennedy pathway are connected by LPCAT1; overex-
pression of LPCAT1 increases degradation of CPT (Butler and 
Mallampalli, 2010). In various mammalian cell lines, LPCAT1 
and LPCAT2 have been localized on LDs (Moessinger et al., 
2011). The LPCAT-mediated synthesis of phosphatidylcholine 
requires an acyl-CoA and lysophosphatidylcholine. The acyl-
CoA can be produced on LDs by ACSL3 and the lysophospha-
tidylcholine by PLA2. The conversion of lysophospholipids into 
phospholipids could be required to protect the nascent globule 
from lipolysis, to avoid coalescence with other LD, or to adapt 
the membrane curvature during LD expansion.
Finally, in adipocytes and hepatocytes, phosphatidyletha-
nolamine methyltransferase (PEMT) also contributes to synthe-
sis of phosphatidylcholine (Vance and Vance, 2004). In cultured 
adipocytes, PEMT localizes to LDs and assembles methyl groups 
to the phosphatidylethanolamine synthesized by decarboxyl-
ation of the phosphatidylserine produced in mitochondria. In 
adipocytes, this pathway can produce a significant portion of 
the LD’s phosphatidylcholine (Hörl et al., 2011). In addition, 
the biosynthesis of ether-linked phospholipids, present in inter-
nal neutral lipids and in the phospholipid monolayer of LDs, 
occurs only in peroxisomes (van den Bosch and de Vet, 1997). 
Thus, although most components required for LD biogenesis 
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complicates the analysis of how each protein regulates LD me-
tabolism (Sztalryd et al., 2006; Bi et al., 2012).
Interestingly, proteins not directly involved in lipid me-
tabolism also regulate LD formation, e.g., proteins related to 
ER-associated degradation of proteins, such as AUP1 or the 
yeast Ubx2/Ubxd8 (Klemm et al., 2011; Spandl et al., 2011; 
and regulates efficient LD formation (Bulankina et al., 2009). 
However, many organisms (e.g., yeast) do not have a Plin3 ortho-
logue, and certain cell types (e.g., Drosophila S2 cells) do not 
express Plin3, suggesting alternative mechanisms of LD forma-
tion (Walther and Farese, 2012), or functional compensation 
between Plin proteins (Sztalryd et al., 2006). Again, redundancy 
Figure 3. Proposed model of LD biogenesis. (A) Summary of the metabolic pathways detailed in Fig. 2 and occurring on LDs. Small circles and cones 
indicate lipids, squares enzymes, and triangles accessory protein. The color of each group follows the legend of Fig. 2. The green box illustrates the 
ACSL3-mediated conversion of the fatty acid into an acyl-CoA. The orange box includes the LD enzymes involved in the local synthesis of triacylglycerol. 
G3-P, glycerol 3-phosphate; LPA, lysophosphatidic acid; PA, phosphatidic acid; DAG, diacylglycerol; TG, triacylglycerol; Pi, inorganic phosphate. The 
green/orange box illustrates the protein complexes of neutral lipid synthesis enzymes (orange box) and synthetase activities (green box) proposed to be a 
cellular mechanism to increase the efficiency of the process by rapidly transferring substrates from one enzyme to the next. The blue and purple box encloses 
reactions of phospholipid synthesis by the Kennedy pathway (using diacylglycerol as substrate, blue circle) and the Lands cycle of phospholipid remodeling 
by deacylation and reacylation of phospholipids (PL) and lysophospholipids (LPL). The gray box includes the accessory proteins (single triangles for cytosolic 
proteins and double triangles for ER-associated proteins). Additional proteins have been added to illustrate in B different mechanisms of protein association 
with LDs. (B) Proposed model of the stepwise formation of LDs. Shapes and colors follow the legend detailed in A. (B1) Before fatty acid arrival—likely bound 
to fatty acid transport proteins (not depicted)—neutral lipid synthesis enzymes and ACSL3 are homogenously distributed in the ER tubules. After lipid arrival 
PAP is recruited to the ER by interaction with Nem1p, perhaps directly to the assembly sites. Lipid intermediates and triacylglycerol are generated along the 
tubules. However, the enzymes in the proximity of ACSL3 will have availability of at least one required substrate. Finally, a triacylglycerol globule is gener-
ated and progressively expands. (B2) At sufficient concentration, the globule of triacylglycerol is not accommodated in the ER membrane, induces phase 
separation, and it is deposited between the two leaflets of the ER bilayer. The resulting membrane curvature—additionally produced/stabilized by local 
lysophospholipids or lipid demixing—is recognized by ER proteins with amphipathic helices, such as ACSL3, which stabilize the globule and mark the onset 
of LD biogenesis. (B3) Transition from a globule into a droplet rapidly occurs by accumulation of ACSL3 that locally increases the acyl-CoA concentration 
and thus efficiently provides to the neighboring enzymes with a substrate required for many reactions. Neutral synthesis enzymes form complexes at the sites 
of assembly, illustrated in A. Now triacylglycerol is rapidly produced at the sites of biogenesis, but in addition this pathway locally generates bioactive lipid 
intermediates. These lipids also determine membrane remodeling and protein recruitment. For example, Plin3 recognizes the accumulation of diacylglycerol 
and binds to the LD. (B4) The nascent LD rapidly expands into the cytosol by packing mobile globules of triacylglycerol arriving from the rest of the ER (B3, 
black arrow) and globules locally produced by the enzyme complexes. New phospholipids, to support LD expansion, are generated in neighboring tubules 
via CPT, and proteins such as seipin and FIT cooperate during the exchange. Conversion of conical lysophospholipids into cylindrical phospholipids, via 
LPCAT, progressively adjusts the growing structure to the new required curvature and, in addition, the cylindrical phospholipids protect the nascent globule 
from lipolytic activities and coalescence. Other proteins are anchored to LDs by interaction with lipid species such as phosphatidic acid and diacylglycerol, 
or by interaction with other LD proteins such as ACSL3. Finally, phosphatidic acid at the base of the structure recruits structural proteins and shapes the 
concave nascent LD into the globular early LD that will progressively expand and move to central regions of the cell to become a mature LD (Fig. 1 F).
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esters (Gorrissen et al., 1980, 1982). Thus, at higher concentra-
tions the neutral lipids likely induce phase separation, and the 
resulting globule is deposited between the two leaflets of the bi-
layer (Fig. 3 B; Suzuki et al., 2011). These globules, with a pre-
dicted diameter of 20 nm (Khandelia et al., 2010), are highly 
mobile and likely move laterally within the membrane (Mountford 
and Wright, 1988). Such a lateral mobility explains why lipid 
globules produced by enzymes excluded from the LD, such as 
Lro1p or ACAT, can efficiently generate LDs. Because triacyl-
glycerol can be enriched in the ER bilayer without inducing LD 
assembly (Chang et al., 2006; Gubern et al., 2008; Adeyo et al., 
2011), additional mechanisms to nucleate LDs are required.
In vitro, a small lipid globule of a few nanometers is suffi-
cient to generate ER membrane curvature stable for at least a 
few microseconds (Khandelia et al., 2010). Also in vitro, it was 
suggested that curvature produced by these globules is sup-
ported, and likely even driven, by gradual demixing of the phos-
pholipids of the monolayer (Zanghellini et al., 2010). However, 
in vivo, local formation of other lipid species such as conical 
lysophospholipids likely generates stronger and more stable mem-
brane bending. For example, although it has a very short half-
life, lysophosphatidic acid has the most positive spontaneous 
curvature of any membrane lipid (Kooijman et al., 2005). Dur-
ing LD assembly, lysophosphatidic acid can be produced by the 
combined activity of GPAT, PLA2, and PLD (Fig. 2). In addi-
tion, the lysophosphatidylcholine produced by PLA2 also posi-
tively curves membranes (Fuller and Rand, 2001). Because 
GPATs have not yet been described in nascent LDs, we favor 
the two lipases as the most likely candidates involved at this 
early stage of biogenesis. Indeed, although the precise role of 
lysophospholipids needs to be experimentally addressed, both 
PLA and PLD are essential for LD formation in vivo and in vitro 
(Marchesan et al., 2003; Andersson et al., 2006; Gubern et al., 
2008; Du et al., 2009).
Amphipathic helices—which can produce membrane 
bending by themselves—also function as membrane curvature 
sensors (McMahon and Gallop, 2005). Thus, once the lipid 
globule has generated bending of the membrane, proteins with 
amphipathic helices and anchored to the ER (and thus in prox-
imity to the globule) will likely recognize this curvature. In-
deed, a significant number of proteins are anchored on LDs by 
amphipathic helices (Walther and Farese, 2012), and thus it is in 
principle an efficient mechanism for recognizing nascent LDs. 
The amphipathic helices are predicted to sit flat on the mem-
brane surface, with the hydrophobic residues dipping into the 
hydrophobic phase of the membrane. The hydrophobic inter-
action of the helix with the membrane is short-range but strong, 
and thus will provide the thermodynamic equilibrium required 
to stabilize a budding structure and mark the onset of LD bio-
genesis (Fig. 3 B). Consistent with this model, in vitro studies 
using ER microsomes from Helianthus annuus show formation 
of globules in the ER bilayer that contained mobile triacylglyc-
erol and that were able to recruit proteins such as oleosin (Lacey 
et al., 1999). 1H-NMR spectroscopy analysis was consistent 
with deposition of these globules in the ER bilayer, and sug-
gested the existence of two populations of globules: a highly 
mobile fraction free of significant amounts of associated proteins 
Wang and Lee, 2012). Similarly, LD biogenesis is promoted by 
unknown mechanisms by many pathogens (Stehr et al., 2012); 
viruses and bacteria often target LDs for nutritional purposes or 
as an anti-immunity strategy (Herker and Ott, 2012; Saka and 
Valdivia, 2012). For example, hepatitis C virus assembles on 
hepatic LDs (Roingeard and Depla, 2011). Intriguingly, hepatic 
cells actively respond to this infection by accumulating anti-
viral proteins on LDs (Hinson and Cresswell, 2009), and we re-
cently demonstrated that histones on LDs protect Drosophila 
against bacterial infections (Anand et al., 2012).
Sites and mechanisms of assembly
So far, we have reviewed biochemical reactions mostly occur-
ring in the ER, and connected to LD formation. In this last section, 
we integrate these data into a single working model describing 
LD biogenesis. We propose a synchronized, stepwise, and self-
reinforcing process involving the ER and triggered by fatty acids.
The ER is a dynamic system of connected membranes 
forming the nuclear envelope, central rough sheet-like struc-
tures, and a polygonal network of tubules extending into the cell 
periphery (Fig. 1 B; Park and Blackstone, 2010). Functionally, 
the ER organizes into microdomains specialized for functions 
such as protein and lipid synthesis, quality control, protein and 
lipid secretion, or detoxification. These microdomains interact 
physically, and highly selective yet poorly understood mecha-
nisms allow their functional segregation. Using model peptides 
to simultaneously visualize the ER and LDs, we have observed 
that when cultured mammalian cells are treated with fatty acids, 
LDs preferentially originate in the network of tubules of the cell 
periphery (Fig. 1 B; Kassan et al., 2013). If lipid arrival continues, 
these LDs expand and, although apparently in contact with the 
ER, progressively move into central regions of the cell (Fig. 1 C). 
A particular lipid composition (phospholipids or free choles-
terol) or the presence of specific proteins (ACSL3, Plin2, Nem1p, 
or seipin) have each been proposed as the mechanism resulting in 
the lateral segregation of these microdomains (Tauchi-Sato et al., 
2002; Robenek et al., 2006; Szymanski et al., 2007; Ohsaki 
et al., 2009; Adeyo et al., 2011; Kassan et al., 2013).
Regardless of the precise ER sites, and although the fol-
lowing model requires much more experimental testing, the cur-
rent belief is that neutral lipid deposition occurs between the two 
leaflets of the ER bilayer (Murphy and Vance, 1999). The 3D 
tomograms of early LDs confirmed that LDs are encircled by a 
single layer (Fig. 1, D and E; green arrow) and demonstrated 
multiple but discrete LD–LD and LD–ER interactions (Fig. 1, 
C and D; white arrow; Kassan et al., 2013). In principle, this mor-
phology rules out vesicle formation models (Walther and Farese, 
2009), being more consistent with the ‘‘blister’’-like organiza-
tion of lipid globules in the bilayer, shown using simulation 
models (Khandelia et al., 2010) and described in early electron 
microscopy studies of the ER of plants (Wanner et al., 1981). 
Because the yeast Lro1p and Dga1p likely have opposite topologi-
cal orientations, neutral lipids produced in both leaflets of the ER 
bilayer can promote LD nucleation (Choudhary et al., 2011).
Initially, newly synthesized neutral lipids seem to be inte-
grated in the ER membrane. However, it is likely that a bilayer only 
accommodates few molar percent of triacylglycerol or cholesterol 
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1995). Physical bridges may permanently connect LDs and the 
ER (Ohsaki et al., 2008; Fujimoto and Parton, 2011; Jacquier 
et al., 2011; Wilfling et al., 2013) and allow active partitioning 
of proteins and lipids between both organelles. Further, the ER–
LD contact can be regulated by proteins such as Rab18 and 
Plin2 (Martin et al., 2005; Ozeki et al., 2005). However, how 
nascent and early LDs move from the periphery and accumulate 
as mature LDs in the cell center will require additional analysis. 
Further, because some LDs have a bidirectional saltatory move-
ment (Pol et al., 2004; Welte, 2009), it seems likely that these 
ER bridges are released under some circumstances.
In conclusion, the assembly of LDs is driven by complex 
but highly robust mechanisms, likely reflecting the physiologi-
cal significance of this organelle even beyond its function in fat 
storage and lipid homeostasis. Indeed, LDs can dynamically ex-
change lipids and proteins with other organelles, and thus pro-
vide timely additional space for sequestration to avoid lipid and 
protein degradation, to keep them inactive, or even to control 
the protein folding state. Their rapid assembly and remodeling 
make LDs well suited to contribute to these processes, and it is 
thus not surprising that altered LD accumulation frequently cor-
relates with disease. Further understanding of the molecules 
and mechanisms involved in LD formation will undoubtedly 
provide additional insights into these disease conditions.
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